Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garry G Graham

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Cancer Letters|September 27, 2005
Oncogenic action of phospholipase A2 in prostate cancerQihan Dong, Manish Patel, Kieran F Scott, et al.
Clinical Pharmacokinetics|July 28, 2007
Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinolRichard O Day, Garry G Graham, Mark Hicks, et al.
Arthritis Research & Therapy|December 18, 2010
A proposal for identifying the low renal uric acid clearance phenotypePraveen L Indraratna, Sophie L Stocker, Kenneth M Williams, et al.
Therapeutic Drug Monitoring|November 29, 2012
Antifungal use and therapeutic monitoring of plasma concentrations of itraconazole in heart and lung transplantation patientsJonathan Brett, OiFong Chong, Garry G Graham, et al.
Therapeutic Drug Monitoring|November 15, 2019
Comparison of the Area Under the Curve for Vancomycin Estimated Using Compartmental and Noncompartmental Methods in Adult Patients With Normal Renal FunctionRashmi V Shingde, Garry G Graham, Stephanie E Reuter, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 9, 2016
Allopurinol: insights from studies of dose-response relationshipsRichard O Day, Diluk R W Kannangara, Sophie L Stocker, et al.
Drug Safety|April 4, 2013
The Role of Metformin in Metformin-Associated Lactic Acidosis (MALA): Case Series and Formulation of a Model of PathogenesisJanna K Duong, Timothy J Furlong, Darren M Roberts, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2020
Assessing the accuracy of two Bayesian forecasting programs in estimating vancomycin drug exposureRashmi V Shingde, Stephanie E Reuter, Garry G Graham, et al.
British Journal of Clinical Pharmacology|February 4, 2012
The pharmacokinetics of oxypurinol in people with goutSophie L Stocker, Andrew J McLachlan, Radojka M Savic, et al.
Therapeutic Drug Monitoring|November 23, 2013
An audit of a therapeutic drug monitoring service for allopurinol therapyDiluk R W Kannangara, Sheena N Ramasamy, John E Ray, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Cancer Letters|September 27, 2005
Oncogenic action of phospholipase A2 in prostate cancerQihan Dong, Manish Patel, Kieran F Scott, et al.
Clinical Pharmacokinetics|July 28, 2007
Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinolRichard O Day, Garry G Graham, Mark Hicks, et al.
Arthritis Research & Therapy|December 18, 2010
A proposal for identifying the low renal uric acid clearance phenotypePraveen L Indraratna, Sophie L Stocker, Kenneth M Williams, et al.
Therapeutic Drug Monitoring|November 29, 2012
Antifungal use and therapeutic monitoring of plasma concentrations of itraconazole in heart and lung transplantation patientsJonathan Brett, OiFong Chong, Garry G Graham, et al.
Therapeutic Drug Monitoring|November 15, 2019
Comparison of the Area Under the Curve for Vancomycin Estimated Using Compartmental and Noncompartmental Methods in Adult Patients With Normal Renal FunctionRashmi V Shingde, Garry G Graham, Stephanie E Reuter, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 9, 2016
Allopurinol: insights from studies of dose-response relationshipsRichard O Day, Diluk R W Kannangara, Sophie L Stocker, et al.
Drug Safety|April 4, 2013
The Role of Metformin in Metformin-Associated Lactic Acidosis (MALA): Case Series and Formulation of a Model of PathogenesisJanna K Duong, Timothy J Furlong, Darren M Roberts, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2020
Assessing the accuracy of two Bayesian forecasting programs in estimating vancomycin drug exposureRashmi V Shingde, Stephanie E Reuter, Garry G Graham, et al.
British Journal of Clinical Pharmacology|February 4, 2012
The pharmacokinetics of oxypurinol in people with goutSophie L Stocker, Andrew J McLachlan, Radojka M Savic, et al.
Therapeutic Drug Monitoring|November 23, 2013
An audit of a therapeutic drug monitoring service for allopurinol therapyDiluk R W Kannangara, Sheena N Ramasamy, John E Ray, et al.
Pageof 5